Skip to main content

Advertisement

Table 1 Demographic and clinical characteristics of subjects

From: Abnormalities of age-related T cell senescence in Parkinson’s disease

Variable PD (n = 41) Controls (n = 41) p
Age (years) 68.4 (6.3) 68.1 (5.6) 0.85
Gender (% male) 68.3 68.3 1.0
Disease duration (years) 4.3 (1.2)   
MDS-UPDRS motor score 34.9 (12.4)   
ACE-R 93.0 (8.3)   
Levodopa equivalent daily dose (mg) 591.5 (292.9)   
CMV IgG (% positive) 46.3 61.0 0.18
  1. Values shown are mean (SD) unless otherwise stated. Continuous variables compared using Student’s t tests and categorical variables compared using chi-square tests or Fisher’s exact test as appropriate
  2. MDS-UPDRS Movement Disorder Society Unified Parkinson’s Disease Rating Scale, ACE-R Addenbrooke’s Cognitive Examination-Revised